VIRGINIA LAW PORTAL

• Code of Virginia
• Virginia Administrative Code
• Constitution of Virginia
• Charters
• Authorities
• Compacts
• Uncodified Acts
• RIS Users (account required)

SEARCHABLE DATABASES

• Bills & Resolutions
  session legislation
• Bill Summaries
  session summaries
• Reports to the General Assembly
  House and Senate documents
• Legislative Liaisons
  State agency contacts

ACROSS SESSIONS

• Subject Index: Since 1995
• Bills & Resolutions: Since 1994
• Summaries: Since 1994

Developed and maintained by the Division of Legislative Automated Systems.

2022 SESSION

• history | hilite | pdf | print version

22102588D
SENATE BILL NO. 73 Offered January 12, 2022 Prefiled January 4, 2022 A BILL to amend the Code of Virginia by adding a section numbered 54.1-3408.6, relating to prescriptions for hydroxychloroquine and ivermectin for treatment of COVID-19. ---------- Patron-- Chase ---------- Referred to Committee on Education and Health ----------

Be it enacted by the General Assembly of Virginia:

1. That the Code of Virginia is amended by adding a section numbered 54.1-3408.6 as follows:

§ 54.1-3408.6. Prescriptions for hydroxychloroquine and ivermectin for treatment of COVID-19.

A. Licensed health care providers with prescriptive authority may prescribe, administer, or dispense hydroxychloroquine and ivermectin to a patient with a clinical diagnosis of COVID-19. The Board of Medicine shall not initiate a disciplinary action against a licensed health care provider and such licensed health care provider shall not be subject to disciplinary action by the Board of Medicine solely for prescribing, administering, or dispensing hydroxychloroquine or ivermectin to a patient with a clinical diagnosis of COVID-19, provided such clinical diagnosis and treatment has been documented in the patient's medical record by such licensed health care provider.

B. Nothing in this section shall be construed to grant any person immunity from investigation or disciplinary action for any other violation of this title.